Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
MOR MorphoSys
4.990-0.020-0.40%
Trading Session
02/07 13:01 ET
High
5.090
Open
5.090
Turnover
129.09K
Low
4.950
Pre Close
5.010
Volume
25.62K
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Sign in to post a comment
ColumnToday's Pre-Market Stock Movers: KMX, RAD, BBBY, MTN and More
Gapping up
In reaction to earnings/guidance:
• $Vail Resorts(MTN.US$ +3.7%,$The Duckhorn Portfolio(NAPA.US$ +2.7%,$Jefferies Financial(JEF.US$ +1.6%
Other news:
• $Axsome Therapeutics(AXSM.US$ +4.3% (disclosesplansto resubmit AXS-07 NDA basedonsuccessfulFDAtype a meeting)
• $Invivyd(IVVD.US$ +4.1% (files for $400mlnmixed securities shelf offering)
• $TRITIUM DCFC LIMITED(DCFC.US$ +3.1%(tosupply fast chargers for Australia's l...
In reaction to earnings/guidance:
• $Vail Resorts(MTN.US$ +3.7%,$The Duckhorn Portfolio(NAPA.US$ +2.7%,$Jefferies Financial(JEF.US$ +1.6%
Other news:
• $Axsome Therapeutics(AXSM.US$ +4.3% (disclosesplansto resubmit AXS-07 NDA basedonsuccessfulFDAtype a meeting)
• $Invivyd(IVVD.US$ +4.1% (files for $400mlnmixed securities shelf offering)
• $TRITIUM DCFC LIMITED(DCFC.US$ +3.1%(tosupply fast chargers for Australia's l...
Like
Comment
Share
ColumnToday's pre-market stock movers: HTZ, SNOW, MRNA, BP and more
Gainers:
• $MorphoSys(MOR.US$ +7.9% (entered into equity participation and license agreements for felzartamab and MOR210)
• $Day One Biopharmaceuticals(DAWN.US$ +7.4% (prices offering of 10 mln shares of common stock at $15.00 per share)
• $Hertz Global(HTZ.US$ +6.1% (authorizes new $2.0 bln share repurchase program)
• $EverCommerce(EVCM.US$ +3.6% (announces $50 million share repurchase program)
• $Sprinklr(CXM.US$ +3.6% (In ...
• $MorphoSys(MOR.US$ +7.9% (entered into equity participation and license agreements for felzartamab and MOR210)
• $Day One Biopharmaceuticals(DAWN.US$ +7.4% (prices offering of 10 mln shares of common stock at $15.00 per share)
• $Hertz Global(HTZ.US$ +6.1% (authorizes new $2.0 bln share repurchase program)
• $EverCommerce(EVCM.US$ +3.6% (announces $50 million share repurchase program)
• $Sprinklr(CXM.US$ +3.6% (In ...
Like
Comment
Share
ColumnToday's pre-market stock movers: ORCL, CLR, NOK, GRPN and more
Gainers:
• $National Vision(EYE.US$ +13.8% (appointed to join S&P SmallCap 600)
• $Braze(BRZE.US$ +12.2% (In reaction to earnings/guidance)
• $Oracle(ORCL.US$ +11.7% (In reaction to earnings/guidance)
• $TeraWulf(WULF.US$ +7.5% (announced recent financing actions and near-term ramp of digital infrastructure)
• $Continental Resources(CLR.US$ +7.5% (announces receipt of "take private" proposal from Hamm Family of $70/share)
•...
• $National Vision(EYE.US$ +13.8% (appointed to join S&P SmallCap 600)
• $Braze(BRZE.US$ +12.2% (In reaction to earnings/guidance)
• $Oracle(ORCL.US$ +11.7% (In reaction to earnings/guidance)
• $TeraWulf(WULF.US$ +7.5% (announced recent financing actions and near-term ramp of digital infrastructure)
• $Continental Resources(CLR.US$ +7.5% (announces receipt of "take private" proposal from Hamm Family of $70/share)
•...
Like
Comment
Share
ColumnToday's pre-market stock movers: GME, GAN, HYZN and more
Gainers:
• $First Advantage(FA.US$ +5.59%, $General Mills(GIS.US$ +3.06%, $Privia Health(PRVA.US$+1.1% (also names new CFO).
Other news:
• $GameStop(GME.US$ +12.1% (continued strength; RC Ventures (Ryan Cohen) increases active stake to 11.9%)
• $Aurora Cannabis(ACB.US$ +7.6% (acquires Terra Fa rm a for $38 mln)
• $Opera(OPRA.US$ +4.9% (sells 42.35% ownership interest in Nanobank for $127,1 mln)
• $MorphoSys(MOR.US$ +2.8% (MOR and INC...
• $First Advantage(FA.US$ +5.59%, $General Mills(GIS.US$ +3.06%, $Privia Health(PRVA.US$+1.1% (also names new CFO).
Other news:
• $GameStop(GME.US$ +12.1% (continued strength; RC Ventures (Ryan Cohen) increases active stake to 11.9%)
• $Aurora Cannabis(ACB.US$ +7.6% (acquires Terra Fa rm a for $38 mln)
• $Opera(OPRA.US$ +4.9% (sells 42.35% ownership interest in Nanobank for $127,1 mln)
• $MorphoSys(MOR.US$ +2.8% (MOR and INC...
Like
Comment
Share
No comment yet
Company Overview
More
MorphoSys AG operates as a commercial-stage biopharmaceutical company. It uses groundbreaking science and technologies to discover, develop, and deliver innovative cancer medicines to patients. The firm also engages in the development and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases. The company was founded by Andreas Pluckthun and Simon E. Moroney in July 1992 and is headquartered in Planegg, Germany.
CEO： Mr. Jean-Paul Kress
Market： NASDAQ
Listing Date： 04/19/2018
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet